Lifetime health consequences and cost-effectiveness of rosiglitazone in combination with metformin for the treatment of type 2 diabetes in Spain
Shearer, Arran T, Bagust, Adrian, Ampudia-Blasco, F Javier, Martínez-Lage Alvarez, Belén, Pérez Escolano, Isabel, París, Gonzalo
Published in PharmacoEconomics (2006)
Published in PharmacoEconomics (2006)
Get full text
Journal Article
Lifetime health consequences and cost-effectiveness of rosiglitazone in combination with metformin for the treatment of type 2 diabetes in Spain: Modelling Life-Time Metabolic Progression and Cost-Effectiveness of Treatment Strategies for Type 2 Diabetes
SHEARER, Arran T, BAGUST, Adrian, AMPUDIA-BLASCO, F. Javier, MARTINEZ-LAGE ALVAREZ, Belen, PEREZ ESCOLANO, Isabel, PARIS, Gonzalo
Published in PharmacoEconomics (2006)
Get full text
Published in PharmacoEconomics (2006)
Journal Article
The Authors' Reply
Martin, Alan, Liebl, Andreas, Goertz, Anita, Perez Escolano, Isabel, Bagust, Adrian, Beale, Sophie, Schoeffski, Oliver, Evans, Marc, Ampudia-Blasco, Javier, Martinez-Lage, Belen, Perry, Andrew, Shearer, Arran, Hulme, Lisa, Home, Philip, Stewart, Murray, Paris, Gonzalo
Published in PharmacoEconomics (2006)
Get full text
Published in PharmacoEconomics (2006)
Journal Article
The Authors??? Reply
Bagust, Adrian A, Evans, Marc, Beale, Sophie, Home, Philip, Perry, Andrew, Stewart, Murray, Shearer, Arran, Martin, Alan, Hulme, Lisa, Liebl, Andreas, Schoeffski, Oliver, Goertz, Anita, Ampudia-Blasco, Javier, Martinez-Lage, Belen, Perez Escolano, Isabel, Paris, Gonzalo
Published in PharmacoEconomics (2006)
Published in PharmacoEconomics (2006)
Get full text
Journal Article